NO20013045L - Nye streptokokkantigener - Google Patents

Nye streptokokkantigener

Info

Publication number
NO20013045L
NO20013045L NO20013045A NO20013045A NO20013045L NO 20013045 L NO20013045 L NO 20013045L NO 20013045 A NO20013045 A NO 20013045A NO 20013045 A NO20013045 A NO 20013045A NO 20013045 L NO20013045 L NO 20013045L
Authority
NO
Norway
Prior art keywords
streptococcal antigens
new
new streptococcal
antigens
streptococcal
Prior art date
Application number
NO20013045A
Other languages
English (en)
Other versions
NO20013045D0 (no
NO330800B1 (no
Inventor
Josee Hamel
Bernard R Brodeur
Isabelle Pineau
Denis Martin
Clement Rioux
Nathalie Charland
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22351610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20013045(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Publication of NO20013045D0 publication Critical patent/NO20013045D0/no
Publication of NO20013045L publication Critical patent/NO20013045L/no
Publication of NO330800B1 publication Critical patent/NO330800B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
NO20013045A 1998-12-23 2001-06-19 Polynukleotid som koder for nye streptokokkantigener, vertscelle og vektor inneholdende polynukleotidet, fremgangsmate for fremstilling, vaksine sammensetning og anvendelse av denne NO330800B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11380098P 1998-12-23 1998-12-23
PCT/CA1999/001218 WO2000039299A2 (en) 1998-12-23 1999-12-20 Streptococcus antigens

Publications (3)

Publication Number Publication Date
NO20013045D0 NO20013045D0 (no) 2001-06-19
NO20013045L true NO20013045L (no) 2001-08-20
NO330800B1 NO330800B1 (no) 2011-07-18

Family

ID=22351610

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013045A NO330800B1 (no) 1998-12-23 2001-06-19 Polynukleotid som koder for nye streptokokkantigener, vertscelle og vektor inneholdende polynukleotidet, fremgangsmate for fremstilling, vaksine sammensetning og anvendelse av denne

Country Status (30)

Country Link
EP (2) EP1141306B1 (no)
JP (2) JP4761623B2 (no)
KR (4) KR100891398B1 (no)
CN (3) CN101134775A (no)
AP (1) AP2001002199A0 (no)
AR (1) AR029322A1 (no)
AT (1) ATE394489T1 (no)
AU (1) AU1764900A (no)
BR (1) BR9916477A (no)
CA (1) CA2356836C (no)
CL (1) CL2009002037A1 (no)
CY (3) CY1108223T1 (no)
CZ (2) CZ302790B6 (no)
DE (1) DE69938670D1 (no)
DK (3) DK1141306T3 (no)
EA (1) EA007409B1 (no)
ES (3) ES2306528T3 (no)
HK (1) HK1118575A1 (no)
HU (1) HU229664B1 (no)
IL (3) IL143905A0 (no)
MX (1) MXPA01006427A (no)
NO (1) NO330800B1 (no)
NZ (1) NZ512574A (no)
OA (1) OA11736A (no)
PL (3) PL205041B1 (no)
PT (3) PT1141306E (no)
TR (2) TR200102497T2 (no)
UY (1) UY25877A1 (no)
WO (1) WO2000039299A2 (no)
ZA (1) ZA200105114B (no)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA11686A (en) 1998-02-20 2005-01-12 Iaf Biochem Int Group B streptococcus antigens.
EP1801218A3 (en) * 1998-07-27 2007-10-10 Sanofi Pasteur Limited Nucleic acids and proteins from streptococcus pneumoniae
US20030134407A1 (en) 1998-07-27 2003-07-17 Le Page Richard William Falla Nucleic acids and proteins from Streptococcus pneumoniae
EP1140157B1 (en) 1998-12-21 2009-02-18 MedImmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
DE69938670D1 (de) * 1998-12-23 2008-06-19 Id Biomedical Corp Streptococcus antigene
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
EP1294771B1 (en) * 2000-06-12 2008-10-29 University Of Saskatchewan Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
MXPA03000103A (es) * 2000-06-20 2003-06-19 Shire Biochem Inc Antigenos de streptococcus.
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
WO2002079475A2 (en) * 2001-03-30 2002-10-10 Shire Biochem Inc. Streptococcus pyogenes antigens and corresponding dna fragments
CA2453062C (en) * 2001-07-06 2013-04-02 Shire Biochem Inc. Group b streptococcus bvh-a5 antigens and corresponding dna fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
WO2003054007A2 (en) * 2001-12-20 2003-07-03 Shire Biochem Inc. Streptococcus antigens
SI1601770T1 (sl) 2003-03-04 2010-01-29 Intercell Ag Streptococcus pyogenes antigeni
CA2522238A1 (en) 2003-04-15 2004-10-28 Intercell Ag S. pneumoniae antigens
CA2633772C (en) 2005-12-22 2015-09-15 Ralph Leon Biemans Pneumococcal polysaccharide conjugate vaccine
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
PL2167121T3 (pl) 2007-06-26 2016-01-29 Glaxosmithkline Biologicals Sa Szczepionka zawierająca koniugaty polisacharydu otoczkowego streptococcus pneumoniae
CA2694466A1 (en) * 2007-07-23 2009-01-29 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies
PT2271360E (pt) 2008-04-16 2015-12-07 Glaxosmithkline Biolog Sa Vacina
US20100092526A1 (en) 2008-09-26 2010-04-15 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
US20120052088A1 (en) 2009-04-30 2012-03-01 Coley Pharmaceutical Group, Inc. Pneumococcal vaccine and uses thereof
US8668911B2 (en) 2009-05-14 2014-03-11 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
ES2670576T3 (es) 2009-09-03 2018-05-31 Pfizer Vaccines Llc Vacuna de PCSK9
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
RU2589256C2 (ru) 2010-12-03 2016-07-10 Санофи Пастер Лимитид Композиции и способы для иммунизации против streptococcus pneumoniae
EP2665490B1 (en) * 2011-01-20 2020-03-04 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
EP2680883B1 (en) 2011-03-02 2018-09-05 Pfizer Inc Pcsk9 vaccine
CA2834834A1 (en) 2011-05-17 2012-11-22 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
JP6316755B2 (ja) * 2012-01-05 2018-04-25 ドイチェス クレープスフォルシュングスツェントルムＤｅｕｔｓｃｈｅｓ Ｋｒｅｂｓｆｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ Ｉｄｈ１ｒ１３２ｈ変異陽性がんを治療または診断する手段および方法
CA2894903A1 (en) * 2012-12-14 2014-06-19 Sanofi Pasteur, Ltd. Methods for assessing immunogenicity
PL3096785T3 (pl) 2014-01-21 2021-03-08 Pfizer Inc. Kompozycje immunogenne zawierające skoniugowane antygeny sacharydów otoczkowych i ich zastosowania
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR102619514B1 (ko) 2014-01-21 2023-12-28 화이자 인코포레이티드 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
DK3096783T3 (da) 2014-01-21 2021-08-02 Pfizer Streptococcus pneumoniae-kapselpolysaccharider og konjugater deraf
ES2930318T3 (es) 2014-02-14 2022-12-09 Pfizer Conjugados glucoproteicos inmunogénicos
HUE062499T2 (hu) 2015-01-15 2023-11-28 Pfizer Pneumococcus-vakcinákban történõ alkalmazásra szolgáló immunogén készítmények
TWI756893B (zh) 2015-07-21 2022-03-01 美商輝瑞股份有限公司 包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
EP3377098A1 (en) 2015-11-20 2018-09-26 Pfizer Inc Immunogenic compositions for use in pneumococcal vaccines
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
RU2762723C2 (ru) 2017-01-20 2021-12-22 Пфайзер Инк. Иммуногенные композиции для применения в пневмококковых вакцинах
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
CA3120922A1 (en) 2018-12-12 2020-06-18 Pfizer Inc. Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
JP7239509B6 (ja) 2019-02-22 2023-03-28 ファイザー・インク 細菌多糖類を精製するための方法
JP2022528158A (ja) 2019-04-10 2022-06-08 ファイザー・インク コンジュゲート化莢膜糖抗原を含む免疫原性組成物、それを含むキットおよびその使用
WO2021021729A1 (en) 2019-07-31 2021-02-04 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
EP4051696A1 (en) 2019-11-01 2022-09-07 Pfizer Inc. Escherichia coli compositions and methods thereof
WO2021165847A1 (en) 2020-02-21 2021-08-26 Pfizer Inc. Purification of saccharides
AU2021223184A1 (en) 2020-02-23 2022-08-18 Pfizer Inc. Escherichia coli compositions and methods thereof
CA3199094A1 (en) 2020-10-22 2022-04-28 Pfizer Inc. Methods for purifying bacterial polysaccharides
KR20230096033A (ko) 2020-10-27 2023-06-29 화이자 인코포레이티드 에스케리키아 콜라이 조성물 및 그의 방법
EP4240410A1 (en) 2020-11-04 2023-09-13 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
US20220202923A1 (en) 2020-12-23 2022-06-30 Pfizer Inc. E. coli fimh mutants and uses thereof
WO2022234405A1 (en) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination against bacterial and betacoronavirus infections
WO2022234416A1 (en) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination against pneumoccocal and covid-19 infections
US20220387576A1 (en) 2021-05-28 2022-12-08 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
EP4346892A2 (en) 2021-05-28 2024-04-10 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2023135515A1 (en) 2022-01-13 2023-07-20 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2023161817A1 (en) 2022-02-25 2023-08-31 Pfizer Inc. Methods for incorporating azido groups in bacterial capsular polysaccharides
WO2023218322A1 (en) 2022-05-11 2023-11-16 Pfizer Inc. Process for producing of vaccine formulations with preservatives

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
HU217582B (hu) * 1993-03-19 2000-02-28 Gunnar Lindahl Streptococcus B csoportba tartozó törzsek elleni immunitást biztosító, Rib fehérjenevű felületi protein, eljárás a protein tisztítására, reagenskészlet és gyógyszerkészítmény
AP9701163A0 (en) * 1995-06-07 1998-01-31 Biochem Vaccines Inc Streptococcal heat shock proteins members of the HSP70 family.
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
WO1998018931A2 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
EP1017828A1 (en) * 1997-09-24 2000-07-12 Regents Of The University Of Minnesota HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
EP1073450A4 (en) * 1998-04-23 2003-04-23 Uab Research Foundation PNEUMOCOCCAL SURFACE PROTEIN C (PSPC), EPITOPIC REGIONS, SELECTION OF CORRESPONDING STRES AND USES
CN1318103A (zh) * 1998-07-27 2001-10-17 微生物技术有限公司 肺炎链球菌的核酸和蛋白质
EP2053126A1 (en) * 1998-07-27 2009-04-29 Sanofi Pasteur Limited Streptococcus pneumoniae proteins and nucleic acid molecules
AU6060899A (en) * 1998-09-24 2000-04-10 American Cyanamid Company Human complement c3-degrading polypeptide from (streptococcus pneumoniae)
EP1140157B1 (en) * 1998-12-21 2009-02-18 MedImmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
DE69938670D1 (de) * 1998-12-23 2008-06-19 Id Biomedical Corp Streptococcus antigene

Also Published As

Publication number Publication date
EA200100565A1 (ru) 2002-04-25
PL349777A1 (en) 2002-09-09
KR100891398B1 (ko) 2009-04-02
KR101078919B1 (ko) 2011-11-01
DK2261358T3 (da) 2014-07-28
HUP0104774A2 (hu) 2002-04-29
CY1115340T1 (el) 2017-01-04
JP2002533123A (ja) 2002-10-08
PT1950302E (pt) 2013-01-16
OA11736A (en) 2005-06-12
EP2261358B1 (en) 2014-05-14
CZ303675B6 (cs) 2013-02-27
ES2480417T3 (es) 2014-07-28
CN1191362C (zh) 2005-03-02
CZ20012161A3 (cs) 2001-10-17
IL194230A (en) 2013-12-31
JP2010142246A (ja) 2010-07-01
CY1108223T1 (el) 2014-02-12
EP2261358A2 (en) 2010-12-15
EP2261358A3 (en) 2011-02-23
PL205041B1 (pl) 2010-03-31
NO20013045D0 (no) 2001-06-19
WO2000039299A3 (en) 2000-11-02
AR029322A1 (es) 2003-06-25
JP4761623B2 (ja) 2011-08-31
NO330800B1 (no) 2011-07-18
DK1141306T3 (da) 2008-08-18
KR101170203B1 (ko) 2012-07-31
CN1654657A (zh) 2005-08-17
NZ512574A (en) 2004-03-26
IL194230A0 (en) 2011-08-01
PT1141306E (pt) 2008-07-30
PT2261358E (pt) 2014-07-30
HK1118575A1 (en) 2009-02-13
EP1141306B1 (en) 2008-05-07
KR20080036666A (ko) 2008-04-28
CZ302790B6 (cs) 2011-11-09
KR20060134227A (ko) 2006-12-27
CA2356836A1 (en) 2000-07-06
IL143905A0 (en) 2002-04-21
EP1141306A2 (en) 2001-10-10
CN1332803A (zh) 2002-01-23
UY25877A1 (es) 2000-08-21
ZA200105114B (en) 2002-11-21
AP2001002199A0 (en) 2001-09-30
CA2356836C (en) 2011-09-13
AU1764900A (en) 2000-07-31
BR9916477A (pt) 2004-06-22
CY1114722T1 (el) 2016-10-05
ES2306528T3 (es) 2008-11-01
CL2009002037A1 (es) 2010-06-25
KR100802198B1 (ko) 2008-02-11
IL143905A (en) 2011-05-31
PL206576B1 (pl) 2010-08-31
ATE394489T1 (de) 2008-05-15
PL204073B1 (pl) 2009-12-31
CN100398653C (zh) 2008-07-02
TR200102497T2 (tr) 2002-01-21
HUP0104774A3 (en) 2007-10-29
KR20100063814A (ko) 2010-06-11
DK1950302T3 (da) 2013-01-14
TR200200633T2 (tr) 2002-06-21
EA007409B1 (ru) 2006-10-27
DE69938670D1 (de) 2008-06-19
MXPA01006427A (es) 2002-06-04
WO2000039299A2 (en) 2000-07-06
HU229664B1 (en) 2014-04-28
CN101134775A (zh) 2008-03-05
JP5039802B2 (ja) 2012-10-03
ES2400280T3 (es) 2013-04-08
KR20010104693A (ko) 2001-11-26

Similar Documents

Publication Publication Date Title
NO20013045D0 (no) Nye streptokokkantigener
NO20026121D0 (no) Streptokokkantigener
NO20004161D0 (no) Gruppe B streptokokkantigener
DE69918109D1 (de) Haarwaschmittel
NO20000312L (no) Nye forbindelser
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
NO20002787D0 (no) Nye forbindelser
NO20006191D0 (no) Vaksine
DE69918909D1 (de) Schweissfreier Abstandshalter
NO20010860D0 (no) Nye forbindelser
NO20010861D0 (no) Nye forbindelser
NO20005857D0 (no) Nye blandinger
DE59910321D1 (de) Drehsperre
IS5694A (is) Bóluefni
DE69903433D1 (de) Plandrehkopf
DE69833263D1 (de) Plattenvorrichtung
DE69833872D1 (de) Plattenvorrichtung
DE69832636D1 (de) Plattenvorrichtung
NO20010584D0 (no) Nye forbindelser
NO20011262D0 (no) Nye forbindelser
NO20005141D0 (no) Streptokokkpreparat
DE69904825D1 (de) Bewegungsbegrenzungseinrichtung
DE59905795D1 (de) Abstandshalter
DE29807427U1 (de) Abstandshalterung
DE29803144U1 (de) Anschlagvorrichtung

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees